Stéphane Chauvie

12PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Aug 26, 2026
Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).

|May 14, 2025
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Rexhep Durmo, Stephane Chauvie, Carla Minoia

|May 13, 2025
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

Maria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo

|Mar 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

|Aug 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone

Pageof 2

Frequent Collaborators

4 joint publications

Antonio Pinto

3 joint publications

Jacopo Olivieri

3 joint publications

Andrea Gallamini

3 joint publications

Luca Guerra